Sponsors (14)
Introduced December 17, 2025 by Julia Brownley · Last progress December 17, 2025
The bill directs substantial federal resources and a coordinated strategy to scale domestic alternative‑protein R&D and biomanufacturing—potentially creating jobs, new markets, and supply resilience—while raising significant taxpayer costs, regulatory and safety challenges, and risks that benefits concentrate with larger firms at the expense of other agricultural priorities and smaller producers.
Scientists, universities, and U.S. biomanufacturers gain sustained federal R&D and commercialization funding and a coordinated strategy to build domestic capacity for alternative proteins, accelerating commercialization and job creation.
Consumers and taxpayers benefit from more diverse, resilient domestic protein supplies and reduced reliance on foreign commodity sources, which can improve food-security resilience and supply-chain stability.
Students, workers, and local communities gain workforce development, training, scholarships, and targeted planning to prepare and attract jobs in food biomanufacturing and related industries.
Taxpayers face materially higher federal spending and new program costs (multiple authorizations and annual appropriations across programs), increasing budgetary outlays without guaranteed near‑term returns.
Public R&D and grant priorities could be redirected toward alternative-protein commercialization, crowding out other agricultural research and priorities (e.g., traditional crops, livestock research).
Program design elements (large minimum grant sizes, capital-focused construction grants, U.S.-ownership/IP requirements) risk concentrating benefits with larger biotech firms and excluding smaller startups, rural producers, and community projects.
Based on analysis of 9 sections of legislative text.
Authorizes federal centers, grants, and an interagency strategy to expand food biomanufacturing, biomass-to-protein conversion, and workforce development with FY2026–FY2030 funding.
Creates federal centers, grant programs, and a national strategy to expand U.S. food biomanufacturing and alternative protein production. The bill authorizes recurring funding for Centers of Excellence, a national protein-security research program, commercial-scale construction and demonstration grants, and workforce development grants, and requires an interagency strategy to coordinate R&D, scale-up, and regulation. Funds and deadlines include annual authorizations from FY2026–FY2030 (centers: $15M/year; national program: $10M/year; construction grants: $50M/year; workforce grants: $25M/year), reporting and program start deadlines within 180 days to one year, and a prohibition on using the law to authorize insect production for human food or animal feed.